Balance Sheet ResMed, Inc.

Equities

RMD

US7611521078

Advanced Medical Equipment & Technology

Real-time Estimate Cboe BZX Other stock markets 13:53:22 13/03/2026 GMT			5-day change	1st Jan Change
234.84 ^USD	+1.04%		-7.37%	-2.76%

03-11	Resmed Insider Sold Shares Worth $1,252,902, According to a Recent SEC Filing	MT
03-11	Baird Adjusts Price Target on ResMed to $272 From $281, Maintains Neutral Rating	MT

f84b8cb.xuPHLNzlUXfSDwp4E6XxY3ygOD-ETAWkEFxcTzBgUL0.i7KzZY-rEwPiPE9VIeaUBR3nWnfOFUHdUhFxOQcRZsmAk65PrtA0OZRLRw

Published financial data: RESMED, INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: June	2021	2022	2023	2024	2025
Revenues	3.2B	3.58B	4.22B	4.69B	5.15B
Total Revenues	3.2B	3.58B	4.22B	4.69B	5.15B
Cost of Goods Sold, Total	1.31B	1.51B	1.84B	2B	2.06B
Gross Profit	1.89B	2.06B	2.39B	2.69B	3.09B
Selling General & Admin Expenses, Total	670M	739M	874M	917M	991M
R&D Expenses	225M	254M	288M	308M	331M
Amortization of Goodwill and Intangible Assets - (IS)	76.2M	70.73M	72.42M	79.48M	77.39M
Other Operating Expenses, Total	972M	1.06B	1.23B	1.3B	1.4B
Operating Income	918M	1B	1.15B	1.38B	1.69B
Interest Expense, Total	-23.99M	-22.31M	-47.38M	-49.72M	-585K
Interest And Investment Income	362K	-	-	-	-
Net Interest Expenses	-23.63M	-22.31M	-47.38M	-49.72M	-585K
Income (Loss) On Equity Invest.	-11.2M	-8.49M	-7.26M	-1.85M	3.64M
Currency Exchange Gains (Loss)	-753K	-	-4.2M	-139K	-2.39M
Other Non Operating Income (Expenses)	1.05M	3.2M	-1.51M	655K	1.83M
EBT, Excl. Unusual Items	883M	973M	1.09B	1.33B	1.69B
Restructuring Charges	-13.9M	-	-9.18M	-64.23M	-
Merger & Related Restructuring Charges	-	-	-10.95M	-	-2.03M
Gain (Loss) On Sale Of Investments	14.52M	-12.2M	9.92M	-4.04M	-10.3M
Insurance Settlements	-	-	20.23M	-	-
Legal Settlements	-	-	-	-	-
EBT, Incl. Unusual Items	884M	960M	1.1B	1.26B	1.68B
Income Tax Expense	409M	181M	204M	244M	277M
Earnings From Continuing Operations	475M	779M	898M	1.02B	1.4B
Net Income to Company	475M	779M	898M	1.02B	1.4B
Net Income - (IS)	475M	779M	898M	1.02B	1.4B
Net Income to Common Incl Extra Items	475M	779M	898M	1.02B	1.4B
Net Income to Common Excl. Extra Items	475M	779M	898M	1.02B	1.4B
Per Share Items
Net EPS - Basic	3.27	5.34	6.12	6.94	9.55
Basic EPS - Continuing Operations	3.27	5.34	6.12	6.94	9.55
Basic Weighted Average Shares Outstanding	145M	146M	147M	147M	147M
Net EPS - Diluted	3.24	5.3	6.09	6.92	9.51
Diluted EPS - Continuing Operations	3.24	5.3	6.09	6.92	9.51
Diluted Weighted Average Shares Outstanding	146M	147M	147M	148M	147M
Normalized Basic EPS	3.8	4.16	4.65	5.67	7.2
Normalized Diluted EPS	3.77	4.13	4.63	5.65	7.17
Dividend Per Share	1.59	1.68	1.76	1.92	2.12
Payout Ratio	47.78	31.48	28.78	27.65	22.19
American Depositary Receipts Ratio (ADR)	0.25	0.25	0.25	0.25	0.25
Supplemental Items
EBITDA	1.03B	1.12B	1.29B	1.53B	1.86B
EBITA	948M	1.04B	1.2B	1.44B	1.74B
EBIT	918M	1B	1.15B	1.38B	1.69B
EBITDAR	1.06B	1.16B	1.33B	1.57B	1.9B
Total Revenues (As Reported)	3.2B	3.58B	4.22B	4.69B	5.15B
Effective Tax Rate - (Ratio)	46.3	18.85	18.53	19.28	16.5
Current Domestic Taxes	-106M	15.08M	50.77M	74.35M	39.66M
Current Foreign Taxes	532M	178M	199M	219M	298M
Total Current Taxes	426M	193M	250M	294M	338M
Deferred Domestic Taxes	-27M	-15.38M	-24.11M	-27.55M	-6.93M
Deferred Foreign Taxes	10.41M	3.57M	-21.32M	-22.33M	-54.06M
Total Deferred Taxes	-16.59M	-11.82M	-45.43M	-49.88M	-60.99M
Normalized Net Income	552M	608M	682M	833M	1.06B
Interest on Long-Term Debt	23.99M	-	47.38M	-	-
Supplemental Operating Expense Items
Research And Development Expense From Footnotes	225M	254M	288M	308M	331M
Net Rental Expense, Total	35.5M	35.3M	33.6M	40.8M	39M
Imputed Operating Lease Interest Expense	6.51M	7.36M	10.2M	13.23M	211K
Imputed Operating Lease Depreciation	28.99M	27.94M	23.4M	27.57M	38.79M
Stock-Based Comp., COGS (Total)	4.15M	5.22M	6.46M	7.56M	8.94M
Stock-Based Comp., R&D Exp. (Total)	8.05M	9.25M	11.63M	14.47M	18.13M
Stock-Based Comp., SG&A Exp. (Total)	51.73M	50.79M	53.05M	58.15M	64.59M
Total Stock-Based Compensation	63.93M	65.26M	71.14M	80.18M	91.66M

Fiscal Period: June	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	295M	274M	228M	238M	1.21B
Short Term Investments	29.08M	-	12.42M	-	-
Total Cash And Short Term Investments	324M	274M	240M	238M	1.21B
Accounts Receivable, Total	625M	602M	736M	837M	991M
Total Receivables	625M	602M	736M	837M	991M
Inventory	457M	851M	1.14B	994M	976M
Prepaid Expenses	95.77M	205M	248M	288M	330M
Other Current Assets, Total	72.41M	-	2.13M	-	-
Total Current Assets	1.57B	1.93B	2.37B	2.36B	3.51B
Gross Property Plant And Equipment	1.21B	1.26B	1.33B	1.43B	1.42B
Accumulated Depreciation	-622M	-633M	-668M	-727M	-705M
Net Property Plant And Equipment	592M	630M	666M	699M	718M
Long-term Investments	40.16M	49.21M	134M	139M	140M
Goodwill	1.93B	1.94B	2.77B	2.84B	3.05B
Other Intangibles, Total	393M	346M	552M	486M	465M
Accounts Receivable Long-Term	6.21M	8.84M	10.08M	18.45M	14.58M
Deferred Tax Assets Long-Term	79.9M	79.75M	133M	204M	253M
Other Long-Term Assets, Total	115M	114M	118M	126M	31.44M
Total Assets	4.73B	5.1B	6.75B	6.87B	8.17B
Liabilities
Accounts Payable, Total	138M	159M	151M	238M	278M
Accrued Expenses, Total	290M	319M	328M	338M	362M
Short-term Borrowings	-	-	-	-	-
Current Portion of Long-Term Debt	12M	9.92M	9.9M	9.9M	9.9M
Current Portion of Leases	23.58M	21.86M	21.92M	25.28M	30.51M
Current Income Taxes Payable	308M	44.89M	72.22M	108M	132M
Unearned Revenue Current, Total	110M	109M	138M	153M	166M
Other Current Liabilities	30.2M	25.89M	37.18M	39.79M	39.92M
Total Current Liabilities	912M	689M	759M	911M	1.02B
Long-Term Debt	643M	765M	1.43B	697M	658M
Long-Term Leases	115M	120M	117M	141M	153M
Unearned Revenue Non Current	91.5M	95.46M	119M	137M	157M
Deferred Tax Liability Non Current	11.32M	9.71M	90.65M	79.34M	77.68M
Other Non Current Liabilities	69.74M	54.86M	105M	42.26M	142M
Total Liabilities	1.84B	1.74B	2.62B	2.01B	2.21B
Common Stock, Total	583K	586K	588K	588K	761K
Additional Paid In Capital	1.62B	1.68B	1.77B	1.9B	2.03B
Retained Earnings	3.08B	3.61B	4.25B	4.99B	6.08B
Treasury Stock	-1.62B	-1.62B	-1.62B	-1.77B	-2.07B
Comprehensive Income and Other	-193M	-313M	-273M	-252M	-74.7M
Total Common Equity	2.89B	3.36B	4.13B	4.86B	5.97B
Total Equity	2.89B	3.36B	4.13B	4.86B	5.97B
Total Liabilities And Equity	4.73B	5.1B	6.75B	6.87B	8.17B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	146M	146M	147M	147M	146M
ECS Total Common Shares Outstanding	146M	146M	147M	147M	146M
Book Value / Share	19.81	22.95	28.08	33.11	40.77
Tangible Book Value	565M	1.08B	807M	1.54B	2.46B
Tangible Book Value Per Share	3.88	7.37	5.49	10.46	16.78
Total Debt	794M	918M	1.58B	874M	852M
Net Debt	469M	644M	1.34B	636M	-358M
Debt Equivalent Oper. Leases	284M	282M	269M	326M	312M
Equity Method Investments, Total	17.15M	9.92M	65.37M	65.46M	76.18M
Account Code - Inventory Valuation	5	5	5	5	5
Inventories - Raw Materials, Total	155M	355M	459M	356M	367M
Inventories - Work In Process, Total	4.65M	3.08M	3.96M	2.71M	2.55M
Inventories - Finished Goods, Total	297M	386M	535M	464M	558M
Land - (BS)	54.46M	51.86M	52.06M	51.98M	51.68M
Buildings, Total	239M	230M	231M	231M	231M
Machinery, Total	714M	769M	831M	890M	850M
Full Time Employees	7.97K	8.16K	10.14K	9.98K	10.6K
Accumulated Allowance for Doubtful Accounts (Supple)	32.14M	23.26M	23.6M	21.13M	22.42M

Fiscal Period: June	2021	2022	2023	2024	2025
Net Income	475M	779M	898M	1.02B	1.4B
Depreciation & Amortization - CF	115M	123M	125M	137M	158M
Amortization of Goodwill and Intangible Assets - (CF)	30.87M	35.18M	47.36M	52.04M	51.92M
Depreciation & Amortization, Total	146M	158M	173M	189M	210M
Amortization of Deferred Charges, Total - (CF)	40.23M	35.54M	25.06M	27.45M	25.47M
(Gain) Loss on Sale of Investments - (CF)	-14.52M	12.2M	-9.92M	4.04M	10.3M
Asset Writedown & Restructuring Costs	13.77M	-	9.18M	33.24M	-
(Income) Loss On Equity Investments - (CF)	11.2M	8.49M	10.14M	1.85M	-3.64M
Stock-Based Compensation (CF)	63.93M	65.26M	71.14M	80.18M	91.66M
Other Operating Activities, Total	-	-	-20.23M	-	-
Change In Accounts Receivable	-129M	19.35M	-107M	-134M	-76.68M
Change In Inventories	-21.95M	-312M	-249M	172M	-80.16M
Change In Accounts Payable	211M	-248M	31.34M	122M	90.96M
Change in Other Net Operating Assets	-58.15M	-168M	-138M	-115M	82.63M
Cash from Operations	737M	351M	693M	1.4B	1.75B
Capital Expenditure	-103M	-135M	-120M	-99.46M	-89.86M
Cash Acquisitions	-39.07M	-42.78M	-1.01B	-133M	-139M
Sale (Purchase) of Intangible assets	-14.11M	-21.2M	-14.33M	-15.4M	-10.78M
Investment in Marketable and Equity Securities, Total	-21.79M	-13.92M	-28.29M	-11.76M	-1.79M
Other Investing Activities, Total	19.22M	-17.18M	15.2M	-9.7M	41.63M
Cash from Investing	-158M	-230M	-1.16B	-270M	-200M
Long-Term Debt Issued, Total	90M	288M	1.07B	105M	-
Total Debt Issued	90M	288M	1.07B	105M	-
Long-Term Debt Repaid, Total	-612M	-166M	-405M	-835M	-40M
Total Debt Repaid	-612M	-166M	-405M	-835M	-40M
Issuance of Common Stock	37.79M	47.38M	49.14M	53.09M	74.44M
Repurchase of Common Stock	-50.21M	-52.41M	-30.63M	-159M	-318M
Common Dividends Paid	-227M	-245M	-258M	-282M	-311M
Common & Preferred Stock Dividends Paid	-227M	-245M	-258M	-282M	-311M
Other Financing Activities, Total	-3.5M	-	-2.36M	-1.29M	-11.71M
Cash from Financing	-765M	-128M	423M	-1.12B	-606M
Foreign Exchange Rate Adjustments	18.5M	-14.43M	-2.15M	-1.72M	25.8M
Net Change in Cash	-168M	-21.57M	-45.82M	10.47M	971M
Supplemental Items
Cash Interest Paid	23.99M	22.31M	47.38M	45.71M	28.42M
Cash Income Tax Paid (Refund)	221M	478M	217M	278M	214M
Levered Free Cash Flow	809M	117M	415M	1.18B	1.21B
Unlevered Free Cash Flow	824M	131M	445M	1.22B	1.21B
Change In Net Working Capital	-117M	597M	410M	-169M	73.56M
Net Debt Issued / Repaid	-522M	122M	665M	-730M	-40M

Fiscal Period: June	2021	2022	2023	2024	2025
Profitability
Return on Assets	12.31	12.73	12.15	12.7	14.02
Return on Total Capital	15.34	15.71	14.42	15.11	16.8
Return On Equity %	17.63	24.96	23.96	22.7	25.86
Return on Common Equity	17.63	24.96	23.96	22.7	25.86
Margin Analysis
Gross Profit Margin %	59.1	57.68	56.5	57.38	59.99
SG&A Margin	20.97	20.66	20.7	19.57	19.26
EBITDA Margin %	32.19	31.42	30.6	32.73	36.15
EBITA Margin %	29.67	28.94	28.4	30.65	33.8
EBIT Margin %	28.7	27.96	27.28	29.54	32.79
Income From Continuing Operations Margin %	14.84	21.78	21.25	21.79	27.22
Net Income Margin %	14.84	21.78	21.25	21.79	27.22
Net Avail. For Common Margin %	14.84	21.78	21.25	21.79	27.22
Normalized Net Income Margin	17.26	16.99	16.16	17.78	20.52
Levered Free Cash Flow Margin	25.29	3.28	9.84	25.29	23.46
Unlevered Free Cash Flow Margin	25.76	3.67	10.54	25.95	23.47
Asset Turnover
Asset Turnover	0.69	0.73	0.71	0.69	0.68
Fixed Assets Turnover	5.67	5.85	6.52	6.87	7.26
Receivables Turnover (Average Receivables)	5.76	5.83	6.31	6.08	5.52
Inventory Turnover (Average Inventory)	2.99	2.3	1.84	1.87	2.09
Short Term Liquidity
Current Ratio	1.73	2.8	3.12	2.59	3.44
Quick Ratio	1.04	1.27	1.29	1.18	2.16
Operating Cash Flow to Current Liabilities	0.81	0.51	0.91	1.54	1.72
Days Sales Outstanding (Average Receivables)	63.33	62.57	57.83	60.23	66.18
Days Outstanding Inventory (Average Inventory)	122	158.52	197.94	195.69	174.63
Average Days Payable Outstanding	37.08	28.53	26.6	38.42	46.13
Cash Conversion Cycle (Average Days)	148.24	192.56	229.16	217.51	194.67
Long Term Solvency
Total Debt/Equity	27.51	27.3	38.26	17.97	14.27
Total Debt / Total Capital	21.57	21.45	27.67	15.23	12.49
LT Debt/Equity	26.27	26.36	37.48	17.24	13.6
Long-Term Debt / Total Capital	20.6	20.7	27.11	14.62	11.9
Total Liabilities / Total Assets	38.97	34.05	38.83	29.22	26.99
EBIT / Interest Expense	38.25	44.83	24.31	27.84	2.88K
EBITDA / Interest Expense	44.37	51.97	27.98	31.67	3.25K
(EBITDA - Capex) / Interest Expense	40.09	45.93	25.45	29.66	3.09K
Total Debt / EBITDA	0.75	0.79	1.19	0.56	0.45
Net Debt / EBITDA	0.44	0.56	1.01	0.4	-0.19
Total Debt / (EBITDA - Capex)	0.83	0.9	1.31	0.59	0.47
Net Debt / (EBITDA - Capex)	0.49	0.63	1.11	0.43	-0.2
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	8.11	11.93	18.02	10.95	9.84
Gross Profit, 1 Yr. Growth %	6.91	9.24	15.61	12.67	14.84
EBITDA, 1 Yr. Growth %	11.5	9.27	14.73	18.69	21.31
EBITA, 1 Yr. Growth %	11.88	9.17	15.62	19.74	21.11
EBIT, 1 Yr. Growth %	13.41	9.01	14.95	20.15	21.91
Earnings From Cont. Operations, 1 Yr. Growth %	-23.67	64.26	15.15	13.75	37.2
Net Income, 1 Yr. Growth %	-23.67	64.26	15.15	13.75	37.2
Normalized Net Income, 1 Yr. Growth %	18.21	10.15	12.01	22.12	26.77
Diluted EPS Before Extra, 1 Yr. Growth %	-24.12	63.58	14.91	13.63	37.43
Accounts Receivable, 1 Yr. Growth %	29.15	-3.77	22.4	18.78	13.16
Inventory, 1 Yr. Growth %	9.62	83.45	34.06	-12.85	-1.86
Net Property, Plant and Equip., 1 Yr. Growth %	10.53	6.49	5.6	5.01	2.74
Total Assets, 1 Yr. Growth %	3.07	7.78	32.49	1.79	18.95
Tangible Book Value, 1 Yr. Growth %	256.51	90.79	-25.14	90.28	59.91
Common Equity, 1 Yr. Growth %	15.56	16.46	22.89	17.78	22.69
Cash From Operations, 1 Yr. Growth %	-8.17	-52.34	97.44	102.11	25
Capital Expenditures, 1 Yr. Growth %	7.74	31.27	-11.25	-16.89	-9.65
Levered Free Cash Flow, 1 Yr. Growth %	40.17	-84.95	225.3	195.78	1.91
Unlevered Free Cash Flow, 1 Yr. Growth %	36.78	-83.47	214.18	181.11	-0.66
Dividend Per Share, 1 Yr. Growth %	1.92	5.66	4.76	9.09	10.42
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	10.75	10	14.93	14.43	10.39
Gross Profit, 2 Yr. CAGR %	10.89	8.06	12.38	14.13	13.75
EBITDA, 2 Yr. CAGR %	16.91	10.38	12.06	16.69	19.99
EBITA, 2 Yr. CAGR %	18.36	10.52	12.45	17.66	20.42
EBIT, 2 Yr. CAGR %	20.12	11.19	12.05	17.52	21.03
Earnings From Cont. Operations, 2 Yr. CAGR %	8.3	11.97	37.53	14.45	24.92
Net Income, 2 Yr. CAGR %	8.3	11.97	37.53	14.45	24.92
Normalized Net Income, 2 Yr. CAGR %	22.28	14.11	11.19	16.96	24.42
Diluted EPS Before Extra, 2 Yr. CAGR %	7.57	11.41	37.1	14.27	24.96
Accounts Receivable, 2 Yr. CAGR %	7.77	11.48	8.53	17.97	18.55
Inventory, 2 Yr. CAGR %	14.33	42.89	56.82	8.09	-7.52
Net Property, Plant and Equip., 2 Yr. CAGR %	23.62	8.49	6.05	5.3	3.87
Total Assets, 2 Yr. CAGR %	7.29	5.4	19.5	16.13	10.03
Tangible Book Value, 2 Yr. CAGR %	35.86	160.81	19.51	19.35	74.44
Common Equity, 2 Yr. CAGR %	18.01	16.01	19.63	20.3	20.21
Cash From Operations, 2 Yr. CAGR %	26.68	-33.84	-2.99	99.76	58.95
Capital Expenditures, 2 Yr. CAGR %	22.26	18.93	7.94	-14.11	-13.34
Levered Free Cash Flow, 2 Yr. CAGR %	38.19	-54.92	-27.01	204.63	73.62
Unlevered Free Cash Flow, 2 Yr. CAGR %	35.89	-53.3	-25.16	193.01	67.11
Dividend Per Share, 2 Yr. CAGR %	2.96	3.77	5.21	6.9	9.75
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	10.96	11.14	12.61	13.59	12.88
Gross Profit, 3 Yr. CAGR %	11.52	10.34	10.52	12.47	14.36
EBITDA, 3 Yr. CAGR %	15.95	14.3	11.87	14.23	18.21
EBITA, 3 Yr. CAGR %	17.37	15.22	12.26	14.83	18.8
EBIT, 3 Yr. CAGR %	17.87	16.29	12.5	14.69	18.97
Earnings From Cont. Operations, 3 Yr. CAGR %	14.56	24.43	13.02	29.1	21.58
Net Income, 3 Yr. CAGR %	14.56	24.43	13.02	29.1	21.58
Normalized Net Income, 3 Yr. CAGR %	17	18.1	13.48	14.72	20.14
Diluted EPS Before Extra, 3 Yr. CAGR %	13.95	23.7	12.56	28.78	21.52
Accounts Receivable, 3 Yr. CAGR %	7.95	3.78	15.01	10.23	18.09
Inventory, 3 Yr. CAGR %	19.37	34.53	39.88	28.93	4.66
Net Property, Plant and Equip., 3 Yr. CAGR %	15.27	17.62	7.52	5.7	4.44
Total Assets, 3 Yr. CAGR %	15.56	7.45	13.75	13.28	17.06
Tangible Book Value, 3 Yr. CAGR %	-9.98	52.14	72.04	39.55	31.57
Common Equity, 3 Yr. CAGR %	11.91	17.49	18.26	19.01	21.1
Cash From Operations, 3 Yr. CAGR %	13.41	-8.54	-4.75	23.9	70.86
Capital Expenditures, 3 Yr. CAGR %	17.96	25.2	7.88	-1.07	-12.65
Levered Free Cash Flow, 3 Yr. CAGR %	16.3	-34.8	-10.4	14.97	111.47
Unlevered Free Cash Flow, 3 Yr. CAGR %	15.7	-33.48	-9.59	15.24	104.31
Dividend Per Share, 3 Yr. CAGR %	3.84	3.85	4.1	6.49	8.06
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	11.7	11.6	12.53	12.44	11.72
Gross Profit, 5 Yr. CAGR %	12.12	11.42	11.86	11.84	11.8
EBITDA, 5 Yr. CAGR %	14.51	14.6	14.37	15.29	15.05
EBITA, 5 Yr. CAGR %	15.58	15.52	15.38	16.23	15.46
EBIT, 5 Yr. CAGR %	16.05	16.97	15.51	16.83	15.84
Earnings From Cont. Operations, 5 Yr. CAGR %	6.13	17.89	23.25	20.34	17.64
Net Income, 5 Yr. CAGR %	6.13	17.89	23.25	20.34	17.64
Normalized Net Income, 5 Yr. CAGR %	14.58	16.58	14.64	17.68	17.74
Diluted EPS Before Extra, 5 Yr. CAGR %	5.41	17.17	22.7	19.84	17.37
Accounts Receivable, 5 Yr. CAGR %	10.35	5.96	8.18	9.24	15.4
Inventory, 5 Yr. CAGR %	15.28	25.97	33.54	23.25	18.54
Net Property, Plant and Equip., 5 Yr. CAGR %	9.03	9.85	11.49	12.53	6.04
Total Assets, 5 Yr. CAGR %	7.74	8	17.12	10.84	12.25
Tangible Book Value, 5 Yr. CAGR %	10.98	11.22	0.82	38.06	72.99
Common Equity, 5 Yr. CAGR %	11.23	11.38	14.94	18.61	19.04
Cash From Operations, 5 Yr. CAGR %	6.1	-3.24	6.54	25.01	16.9
Capital Expenditures, 5 Yr. CAGR %	11.9	16.73	13.84	7.68	-1.17
Levered Free Cash Flow, 5 Yr. CAGR %	14.82	-13.49	-4.17	22.85	15.9
Unlevered Free Cash Flow, 5 Yr. CAGR %	14.84	-12.76	-3.5	22.21	14.94
Dividend Per Share, 5 Yr. CAGR %	5.27	4.63	4.39	5.06	6.33